1. A phase II study of combined therapy with a BRAF inhibitor (vemurafenib) and interleukin-2 (aldesleukin) in patients with metastatic melanoma. (4th May 2018) Authors: Mooradian, Meghan J.; Reuben, Alexandre; Prieto, Peter A.; Hazar-Rethinam, Mehlika; Frederick, Dennie T.; Nadres, Brandon; Piris, Adriano; Juneja, Vikram; Cooper, Zachary A.; Sharpe, Arlene H.; Corcoran, Ryan B.; Flaherty, Keith T.; Lawrence, Donald P.; Wargo, Jennifer A.; Sullivan, Ryan J. Journal: Oncoimmunology Issue: Volume 7:Number 5(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Author Correction: Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma. (December 2018) Authors: Amaria, Rodabe; Reddy, Sangeetha; Tawbi, Hussein; Davies, Michael; Ross, Merrick; Glitza, Isabella; Cormier, Janice; Lewis, Carol; Hwu, Wen-Jen; Hanna, Ehab; Diab, Adi; Wong, Michael; Royal, Richard; Gross, Neil; Weber, Randal; Lai, Stephen; Ehlers, Richard; Blando, Jorge; Milton, Denái; Woodman,... Journal: Nature medicine Issue: Volume 24:Number 12(2018) Page Start: 1941 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma. (November 2018) Authors: Amaria, Rodabe; Reddy, Sangeetha; Tawbi, Hussein; Davies, Michael; Ross, Merrick; Glitza, Isabella; Cormier, Janice; Lewis, Carol; Hwu, Wen-Jen; Hanna, Ehab; Diab, Adi; Wong, Michael; Royal, Richard; Gross, Neil; Weber, Randal; Lai, Stephen; Ehlers, Richard; Blando, Jorge; Milton, Denái; Woodman,... Journal: Nature medicine Issue: Volume 24:Number 11(2018) Page Start: 1649 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Neoadjuvant plus adjuvant dabrafenib and trametinib versus standard of care in patients with high-risk, surgically resectable melanoma: a single-centre, open-label, randomised, phase 2 trial. Issue 2 (February 2018) Authors: Amaria, Rodabe N; Prieto, Peter A; Tetzlaff, Michael T; Reuben, Alexandre; Andrews, Miles C; Ross, Merrick I; Glitza, Isabella C; Cormier, Janice; Hwu, Wen-Jen; Tawbi, Hussein A; Patel, Sapna P; Lee, Jeffrey E; Gershenwald, Jeffrey E; Spencer, Christine N; Gopalakrishnan, Vancheswaran; Bassett, R... Journal: Lancet oncology Issue: Volume 19:Issue 2(2018) Page Start: 181 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Publisher Correction: Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma. (December 2018) Authors: Amaria, Rodabe; Reddy, Sangeetha; Tawbi, Hussein; Davies, Michael; Ross, Merrick; Glitza, Isabella; Cormier, Janice; Lewis, Carol; Hwu, Wen-Jen; Hanna, Ehab; Diab, Adi; Wong, Michael; Royal, Richard; Gross, Neil; Weber, Randal; Lai, Stephen; Ehlers, Richard; Blando, Jorge; Milton, Denái; Woodman,... Journal: Nature medicine Issue: Volume 24:Number 12(2018) Page Start: 1942 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗